Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Circ Cardiovasc Imaging. 2018 Jun;11(6):e007394. doi: 10.1161/CIRCIMAGING.117.007394

Table 4.

Change in advanced lipoprotein characterization, glucose metabolism, and inflammation between baseline and Week 12, by treatment group during RCT period

Adalimumab vs Placebo1 Phototherapy vs Placebo1 F-test p2
TC 6.481 (0.386) 8.154 (0.280) 0.514
Efflux 0.046 (0.357) 0.035 (0.496) 0.629
LDL-P 9.193 (0.897) 52.320 (0.467) 0.743
HDL-P 2.558 (0.089) 3.319 (0.030) 0.071
Log Insulin 0.014 (0.934) 0.071 (0.679) 0.909
Log Adiponectin −0.142 (0.672) −0.151 (0.655) 0.879
Log Leptin −0.086 (0.504) 0.050 (0.695) 0.568
Log CRP −0.883 (0.002) −0.752 (0.009) 0.004
Log TNF-alpha −0.411 (<0.001) −0.177 (0.065) <0.001
Log IL6 −0.764 (0.007) −0.683 (0.019) 0.014
GlycA −41.165 (0.006) −7.199 (0.628) 0.015
1

Difference of differences (statistically significant findings bolded)

2

Global difference (statistically significant findings bolded)